Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout

OBJECTIVE: Patients with uncontrolled/refractory gout have heavy disease burden, but few treatment options. Pegloticase lowers serum urate (SU), but anti-drug antibodies can limit treatment efficacy. Evidence supports immunomodulator-pegloticase co-administration to increase sustained urate-lowering...

Descripción completa

Detalles Bibliográficos
Autores principales: Broadwell, Aaron, Albert, John A., Padnick-Silver, Lissa, LaMoreaux, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561461/
https://www.ncbi.nlm.nih.gov/pubmed/36136270
http://dx.doi.org/10.1007/s40744-022-00492-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561461/
https://www.ncbi.nlm.nih.gov/pubmed/36136270
http://dx.doi.org/10.1007/s40744-022-00492-3

Ejemplares similares